about bpl

Bio Products Laboratory Ltd.


PRESS RELEASE - Bio Products Laboratory, Ltd. Announces Results from Phase III Registration Study of its Factor X Coagulation Product

ELSTREE, UK AND DURHAM, NC - April 17, 2015 - Bio Products Laboratory, Ltd. (BPL), a leading manufacturer of plasma-derived protein therapies, today announced the results from a phase III registration study examining the pharmacokinetics, efficacy, and safety of its FACTOR X coagulation product in ...

Date added: Monday 27th April 2015
Latest updated: Wednesday 8th February 2017

Patient information leaflets